We are live on ! Find out more
KC

Knuff & Co Portfolio holdings

AUM $332M
1-Year Est. Return 21.75%
This Fund
S&P 500
This Quarter Est. Return
+9.87%
1 Year Est. Return
+21.75%
3 Year Est. Return
+73.7%
5 Year Est. Return
+109.83%
10 Year Est. Return
AUM
$167M
AUM Growth
+$21.7M
Cap. Flow
+$10.1M
Cap. Flow %
6.06%
Top 10 Hldgs %
48.36%
Holding
191
New
9
Increased
62
Reduced
14
Closed
18

Sector Composition

1 Technology 19.14%
2 Consumer Staples 17.45%
3 Industrials 14.26%
4 Healthcare 12.8%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BEN icon
176
Franklin Resources
BEN
$17.3B
-2,000
Closed -$58K
DD icon
177
DuPont de Nemours
DD
$18.1B
-204
Closed -$18K
DOW icon
178
Dow Inc
DOW
$21.1B
-256
Closed -$12K
JWN
179
DELISTED
Nordstrom
JWN
-800
Closed -$27K
KDP icon
180
Keurig Dr Pepper
KDP
$42.7B
-5,102
Closed -$139K
KMI icon
181
Kinder Morgan
KMI
$72.4B
-1,000
Closed -$21K
PGR icon
182
Progressive
PGR
$120B
-85
Closed -$7K
R icon
183
Ryder
R
$10.6B
-400
Closed -$21K
RLJ icon
184
RLJ Lodging Trust
RLJ
$1.78B
-387
Closed -$7K
SNA icon
185
Snap-on
SNA
$21.5B
-151
Closed -$24K
VMI icon
186
Valmont Industries
VMI
$10.5B
-400
Closed -$55K
WDC icon
187
Western Digital
WDC
$161B
-662
Closed -$30K
MDP
188
DELISTED
Meredith Corporation
MDP
-332
Closed -$12K
CLGX
189
DELISTED
Corelogic, Inc.
CLGX
-600
Closed -$28K
CELG
190
DELISTED
Celgene Corp
CELG
-31,715
Closed -$3.15M
CADE
191
DELISTED
Cadence Bancorporation
CADE
-632
Closed -$11K

Similar funds

Knuff & Co's Q4 2019 Portfolio in Review

As of Q4 2019, Knuff & Co held 191 positions worth $167M, up 15% from $145M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Knuff & Co deployed $10.1M of net new capital in Q4 2019, opening 9 new positions and adding to 62 existing holdings. Its largest new stake was AstraZeneca: 1,100 shares worth $110K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Staples and Industrials.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $239K trimmed.

  • Knuff & Co's largest Q4 2019 buy was AstraZeneca: 1,100 shares worth $110K.
  • Knuff & Co added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.95M increase.
  • Knuff & Co's biggest Q4 2019 reduction was Alphabet (Google) Class C, cutting an estimated $239K.
  • Knuff & Co fully exited Celgene Corp in Q4 2019, selling an estimated $3.15M.
  • Knuff & Co's ten largest holdings make up 48% of its $167M portfolio in Q4 2019.
  • Knuff & Co opened 9 new positions and closed 18 in Q4 2019.
  • Knuff & Co's portfolio value rose 15% quarter-over-quarter to $167M.

Based on Knuff & Co's 13F filing for Q4 2019, filed 11 Feb 2020.